199 related articles for article (PubMed ID: 35003085)
21. Constructing and validating a risk model based on neutrophil-related genes for evaluating prognosis and guiding immunotherapy in colon cancer.
Wang S; Wang L; Qiu M; Lin Z; Qi W; Lv J; Wang Y; Lu Y; Li X; Chen W; Qiu W
J Gene Med; 2024 Apr; 26(4):e3684. PubMed ID: 38618694
[TBL] [Abstract][Full Text] [Related]
22. Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction.
Li N; Yu K; Huang D; Zhou H; Zeng D
Curr Med Chem; 2024; 31(12):1578-1594. PubMed ID: 37650393
[TBL] [Abstract][Full Text] [Related]
23. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
[TBL] [Abstract][Full Text] [Related]
24. A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes.
Wang J; Jiang L; Shang Z; Ye Z; Yuan D; Cui X
Cancer Biother Radiopharm; 2024 May; 39(4):306-317. PubMed ID: 37610864
[No Abstract] [Full Text] [Related]
25. Identification of signature of tumor-infiltrating CD8 T lymphocytes in prognosis and immunotherapy of colon cancer by machine learning.
Liao K; Yang Q; Xu Y; He Y; Wang J; Li Z; Wu C; Hu J; Wang X
Clin Immunol; 2023 Dec; 257():109811. PubMed ID: 37858752
[TBL] [Abstract][Full Text] [Related]
26. Immune response drives outcomes in prostate cancer: implications for immunotherapy.
Meng J; Zhou Y; Lu X; Bian Z; Chen Y; Zhou J; Zhang L; Hao Z; Zhang M; Liang C
Mol Oncol; 2021 May; 15(5):1358-1375. PubMed ID: 33338321
[TBL] [Abstract][Full Text] [Related]
27. Identification of the new molecular subtypes related to inflammation in breast cancer.
Yu K; Xu C; Wang F; Wang H
Medicine (Baltimore); 2024 May; 103(19):e38146. PubMed ID: 38728446
[TBL] [Abstract][Full Text] [Related]
28. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.
Wang Y; He J; Zhao Q; Bo J; Zhou Y; Sun H; Ding B; Ren M
Front Immunol; 2024; 15():1416914. PubMed ID: 38817605
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive pan-cancer analysis of inflammatory age-clock-related genes as prognostic and immunity markers based on multi-omics data.
Yan B; Liao P; Liu S; Lei P
Sci Rep; 2024 May; 14(1):10468. PubMed ID: 38714870
[TBL] [Abstract][Full Text] [Related]
31. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
Lu W; Wang Q; Liu L; Luo W
Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
[TBL] [Abstract][Full Text] [Related]
32. CD48 suppresses proliferation and migration as an immune-related prognostic signature in the cervical cancer immune microenvironment.
Ma Y; Yang Z; Liu J; Wang D
Carcinogenesis; 2024 Feb; 45(1-2):57-68. PubMed ID: 37279525
[TBL] [Abstract][Full Text] [Related]
33. Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer.
Wang HY; Diao Y; Tan PZ; Liang H
World J Gastrointest Oncol; 2024 May; 16(5):1908-1924. PubMed ID: 38764831
[TBL] [Abstract][Full Text] [Related]
34. Downregulated expression of plakophilin-2 gene in patients with colon adenocarcinoma predicts an unfavorable prognosis and immune infiltrate.
Dai M; Su Y; Wu Z
J Gene Med; 2024 Jan; 26(1):e3592. PubMed ID: 37726168
[TBL] [Abstract][Full Text] [Related]
35. An integrated tumor, immune and microbiome atlas of colon cancer.
Roelands J; Kuppen PJK; Ahmed EI; Mall R; Masoodi T; Singh P; Monaco G; Raynaud C; de Miranda NFCC; Ferraro L; Carneiro-Lobo TC; Syed N; Rawat A; Awad A; Decock J; Mifsud W; Miller LD; Sherif S; Mohamed MG; Rinchai D; Van den Eynde M; Sayaman RW; Ziv E; Bertucci F; Petkar MA; Lorenz S; Mathew LS; Wang K; Murugesan S; Chaussabel D; Vahrmeijer AL; Wang E; Ceccarelli A; Fakhro KA; Zoppoli G; Ballestrero A; Tollenaar RAEM; Marincola FM; Galon J; Khodor SA; Ceccarelli M; Hendrickx W; Bedognetti D
Nat Med; 2023 May; 29(5):1273-1286. PubMed ID: 37202560
[TBL] [Abstract][Full Text] [Related]
36. Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy.
Wang C; Li Y; Huang J; Yan H; Zhao B
Mol Cancer; 2024 Apr; 23(1):81. PubMed ID: 38658978
[TBL] [Abstract][Full Text] [Related]
37. Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer.
Lei J; Luo J; Liu Q; Wang X
Cell Oncol (Dordr); 2024 Apr; 47(2):587-605. PubMed ID: 37821797
[TBL] [Abstract][Full Text] [Related]
38. Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single-cell sequencing analysis.
Chen W; Liu X; Wang H; Dai J; Li C; Hao Y; Jiang D
J Cell Mol Med; 2024 May; 28(10):e18379. PubMed ID: 38752750
[TBL] [Abstract][Full Text] [Related]
39. Expression, prognostic value and potential immunotherapeutic target of COL1A1 in colon cancer.
Zeng X; Chen G; Guo D; Chen Y; Hu X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):120-125. PubMed ID: 38279475
[TBL] [Abstract][Full Text] [Related]
40. Identification of Key Components in Colon Adenocarcinoma Using Transcriptome to Interactome Multilayer Framework.
Pournoor E; Mousavian Z; Dalini AN; Masoudi-Nejad A
Sci Rep; 2020 Mar; 10(1):4991. PubMed ID: 32193399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
